| Ref. | Indicator | Strata |
| 1. | Demographic characteristics | |
| 1.1 | Age (Classes) | Gender |
| 1.2 | Gender | Age |
| 2. | Clinical characteristics | |
| 2.1 | Diabetes status | |
| 2.1.1 | Type of diabetes | Age |
| 2.1.2 | Duration of diabetes | Type of diabetes
Gender
Hba1c |
| 2.2 | Risk factors for diabetes complications | |
| 2.2.1 | Obesity | |
| 2.2.1.1 | Weight | Gender
Age
Type of diabetes |
| 2.2.1.2 | BMI | Gender
Age
Type of diabetes |
| 2.2.2 | Lifestyle | |
| 2.2.2.1 | Smoking status | Gender
Age
Type of diabetes |
| 2.2.3 | Clinical measurements | |
| 2.2.3.1 | Systolic BP | Gender
Age
Type of diabetes |
| 2.2.3.2 | Diastolic BP | Gender
Age
Type of diabetes |
| 2.2.3.3 | Total cholesterol | Gender
Age
Type of diabetes |
| 2.2.3.4 | HDL-cholesterol | Gender
Age
Type of diabetes |
| 2.2.3.5 | Creatinine | Gender
Age
Type of diabetes |
| 2.2.3.6 | HbA1c | Gender
Age
Type of diabetes |
| 2.3 | Diabetes complications | |
| 2.3.1 | Retinopathy | Diabetes duration |
| 2.3.2 | End stage renal failure | Diabetes duration |
| 2.3.3 | Foot ulcer | Diabetes duration |
| 2.3.4 | Lower etremity amputation | Diabetes duration |
| 2.3.5 | Stroke | Diabetes duration |
| 2.3.6 | Myocardial infarction | Diabetes duration |
| 2.3.7 | Hypertension | Diabetes duration |
| 3. | Health system | |
| 3.1 | Structure (provider level) | |
| 3.1.1 | Type of provider | |
| 3.1.2 | Average diabetes population per centre | Gender
Age
Type of diabetes |
| 3.2 | Structural quality | |
| 3.2.1 | Hospital beds per 100,000 population | Region |
| 3.2.2 | Physicians employed per 100,000 population | Region |
| 3.3 | Processes | |
| 3.3.1 | Foot eamination | |
| 3.3.1.1 | Done | Age
Type of diabetes |
| 3.3.2 | Eye eamination | |
| 3.3.2.1 | Done | Age
Type of diabetes |
| 3.3.3 | Measurement done | |
| 3.3.3.1 | BP done | Age
Type of diabetes |
| 3.3.3.2 | Lipids done | Age
Type of diabetes |
| 3.3.3.3 | Microalbumin done | Age
Type of diabetes |
| 3.3.3.4 | HbA1c done | Age
Type of diabetes |
| 3.3.4 | Treatment | |
| 3.3.4.1 | Antihypertensive medication | Age
Type of diabetes |
| 3.3.4.2 | Lipid lowering treatment | Age
Type of diabetes |
| 3.3.4.3 | ASA treatment (Aspirin) | Age
Type of diabetes |
| 3.3.4.4 | Glucose lowering treatment |
| 3.3.4.4.1 | Diet only | Age
Type of diabetes |
| 3.3.4.4.2 | Tablets: 1. Sulphonyureas, 2. Biguanides, 3. Glucosidase Inhibitors,4. Glitazones, 5. Glinides, 6. Other | Age Type of diabetes |
| 3.3.4.4.3 | Insulin only | Age
Type of diabetes |
| 3.3.4.4.4 | Insulin and tablets | Age
Type of diabetes |
| 3.3.4.4.5 | Insulin pump | Age
Type of diabetes |
| 3.3.5 | Management | |
| 3.3.5.1 | Self-monitoring | Age
Type of diabetes |
| 3.3.5.2 | Visit frequency | Age
Type of diabetes |
| 4. | Population | |
| 4.1 | Area level | |
| 4.1.1 | Total population | Age
Gender |
| 4.1.2 | Life expectancy | Age
Gender |
| 4.1.3 | Mortality data | Age
Gender |
| 5. | Risk adjusted indicators | |
| 5.1 | Epidemiology | |
| 5.1.1 | Prevalence of diabetes mellitus per 1,000 | Region
Type of diabetes |
| 5.1.2 | Age at diagnosis by 10 year age bands (incidence) | Region
Type of diabetes |
| 5.2 | Process quality | |
| 5.2.1 | % of persons with diabetes with one or more HbA1c tests during the last 12 months | Region
Gender
Age
Type of diabetes |
| 5.2.2 | % of persons with diabetes with at least one test for microalbuminuria during the last 12 months | Region
Gender
Age
Type of diabetes |
| 5.2.3 | % of persons with diabetes who received a dilated eye examination or evaluation of retinal photography by a trained caregiver within the last 12 months | Region
Gender
Age
Type of diabetes |
| 5.2.4 | % of persons with diabetes receiving at least one examination of the feet within the last 12 months | Region
Gender
Age
Type of diabetes |
| 5.2.5 | % of persons with diabetes whose smoking status was ascertained and documented within the last 12 months | Region
Gender
Age
Type of diabetes |
| 5.2.6 | % with serum creatinine tested in last 12 months | Region
Gender
Age
Type of diabetes |
| 5.2.7 | % of persons with diabetes and one or more blood pressure measurements within the last 12 months | Region
Gender
Age
Type of diabetes |
| 5.2.8 | % of persons with diabetes with hypertension who receive antihypertensive medication | Region
Gender
Age
Type of diabetes |
| 5.2.9 | Type of oral therapy (distribution of agents) in persons with diabetes type 2 | Country
Gender
Age |
| 5.2.10 | % of persons treated with insulin among persons with diabetes | Region
Gender
Age
Type of diabetes |
| 5.2.11 | % of persons treated with insulin in combination with OADs among persons with diabetes | Country
Gender
Age |
| 5.2.12 | % of insulin treated persons with diabetes with insulinpump therapy | Region
Gender
Age
Type of diabetes |
| 5.2.13 | % of persons with diabetes with anti hypertensive treatment | Region
Gender
Age
Type of diabetes |
| 5.2.14 | % of persons with diabetes with lipid lowering treatment | Region
Gender
Age
Type of diabetes |
| 5.2.15 | % of persons with diabetes with ASA treatment | Region
Gender
Age
Type of diabetes |
| 5.2.16 | % of persons with diabetes performing self-monitoring of blood glucose | Region
Gender
Age
Type of diabetes |
| 5.3 | Outcome quality-intermediate outcomes | |
| 5.3.1 | % of persons with diabetes with most recent HbA1c level >9.0% | Region
Gender
Age
Type of diabetes |
| 5.3.2 | % of persons with diabetes with most recent HbA1c level >7,5% | Region
Gender
Age
Type of diabetes |
| 5.3.3 | % of persons with diabetes with most recent blood pressure less than 140/90 mmHg | Region
Gender
Age
Type of diabetes |
| 5.3.4 | % of persons with diabetes with BMI = 30 | Region
Gender
Age
Type of diabetes |
| 5.3.5 | % of persons with diabetes with microalbuminuria in last 12 months (among those who have been tested) | Region
Gender
Age
Type of diabetes |
| 5.3.6 | % of persons with diabetes who currently smoke among persons with diabetes | Region
Gender
Age
Type of diabetes |
| 5.3.7 | % of persons with diabetes with former or current foot ulceration | Region
Gender
Age
Type of diabetes |
| 5.4 | Outcome Quality - Terminal outcomes | |
| 5.4.1 | Annual incidence of dialysis and/or transplantation (renal replacement therapy) per 100,000 populations in persons with diabetes | Region
Gender
Age
Type of diabetes |
| 5.4.2 | % of persons with diabetes with ESRD | Region
Gender
Age
Type of diabetes |
| 5.4.3 | Annual death rate per 100,000 populations in the general population from all causes, adjusted for standard European population. Annual death rate per 100,000 populations in persons, who have as primary or secondary cause of death, diabetes mellitus, adjusted for standard European population | Region |
